Abbott Labs Receives Preliminary Settlement Approval for Lawsuits

Abbott Laboratories announced that the U.S. District Court for the Northern District of Illinois has preliminarily approved a proposed settlement for six consolidated shareholder derivative lawsuits. These lawsuits, previously disclosed in the company's annual reports, were filed against certain current and former directors and officers regarding infant formula. The court's order, issued on April 10, 2026, directs the issuance of notice and sets a final settlement hearing, moving towards a resolution of the litigation.